Establishment of chimeric rabbits with FOXN1 gene knockout
Author:
Affiliation:

1.Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine, School of Biotechnology and Health Sciences, Wuyi University;2.Guangdong Medical Laboratory Animal Center, Guangdong Provincial People'3.'4.s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University

Fund Project:

Supported by National Natural Science Foundation of China (No. 82101937); Supported by Science and Technology Planning Project of Guangdong Province, China (No. 2019A030317012); Supported by Science and Technology Planning Project of Guangdong Province, China (No. 2021B1212040016).

  • Article
  • | |
  • Metrics
  • |
  • Reference [12]
  • | |
  • Cited by
  • | |
  • Comments
    Abstract:

    Objective The aim of this study was to establish F0 generation chimeric rabbits with FOXN1 gene knockout to explore methods for in vivo conservation of immunodeficient rabbits in a conventional housing environment. Methods Initially, the CRISPR/Cas9 technology was employed to inject the constructed sgRNA and Cas9 protein into a single cell of rabbit two-cell stage embryos to obtain chimeric embryos with FOXN1 gene editing. Subsequently, the embryos were transferred into surrogate does. Finally, the F0 generation offspring were genotyped using PCR and Sanger sequencing, and their growth and development in a conventional housing environment were observed. Results The PCR and Sanger sequencing results confirmed the successful establishment of chimeric rabbits with FOXN1 gene knockout. Observation revealed that the chimeras exhibited normal growth and development in a conventional environment without any immunodeficient phenotypes. Conclusion This study has initially established a chimeric rabbit model with FOXN1 gene knockout, which can grow and develop normally in ordinary environments. This lays the foundation for further breeding of FOXN1 immunodeficient rabbits in the future.

    Reference
    [1] 朱敬之, 吴志勇.免疫缺陷鼠异种原位移植性乳腺癌模型[J].现代肿瘤医学, 2011,19(12):2564-2567.
    [2] 周箴, 徐云华, 张菲菲, 等.人源化免疫肺癌小鼠模型的建立及其在程序性死亡受体1抑制剂疗效评估中的作用[J].上海交通大学学报(医学版), 2020,40(01):37-43.
    [3] 白家驷, 毛青.应用CRISPR/Cas9技术构建Tet-on调控表达uPA的人源化肝细胞嵌合小鼠[J].陆军军医大学学报, 2023,45(13):1405-1412.
    [4] 赵宁宁, 张正, 王彦博, 等.基于人源化免疫重建的患者来源肿瘤组织异种移植模型的研究进展[J].中国实验动物学报, 2018,26(06):804-808.
    [5] 刘甦苏, 吴勇, 曹愿, 等.hKDR~(+/+)人源化及Rag1~(-/-)基因缺陷新型双靶点遗传修饰荷瘤小鼠模型的建立[J].实验动物与比较医学, 2023,43(02):103-111.
    [6] 尹媛, 曾文滔, 周建丽, 等.Prkdc和Il2rg双敲除免疫缺陷小鼠的构建和初步应用[J].南京医科大学学报(自然科学版), 2022,42(08):1107-1111.
    [7] 何啸, 胡雨萌, 宋银宏.转录调节因子FOXN1异常表达引起相关疾病的研究进展[J].基础医学与临床, 2019,39(02):264-267.
    [8] Zhang Z, Burnley P, Coder B, et al. Insights on FoxN1 biological significance and usages of the "nude" mouse in? studies of T-lymphopoiesis[J]. Int J Biol Sci, 2012,8(8):1156-1167.
    [9] Song J, Hoenerhoff M, Yang D, et al. Development of the Nude Rabbit Model[J]. Stem Cell Reports, 2021,16(3):656-665.
    [10] Boettcher A N, Loving C L, Cunnick J E, et al. Development of Severe Combined Immunodeficient (SCID) Pig Models for Translational Cancer Modeling: Future Insights on How Humanized SCID Pigs Can? Improve Preclinical Cancer Research[J]. Front Oncol, 2018,8:559.
    [11] Wu Y, Zhang J, Peng B, et al. Generating viable mice with heritable embryonically lethal mutations using the? CRISPR-Cas9 system in two-cell embryos[J]. Nat Commun, 2019,10(1):2883.
    [12] Chen B, Gu P, Jia J, et al. Optimization Strategy for Generating Gene-edited Tibet Minipigs by Synchronized? Oestrus and Cytoplasmic Microinjection[J]. Int J Biol Sci, 2019,15(12):2719-2732.
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 15,2023
  • Revised:March 01,2024
  • Adopted:May 06,2024
Article QR Code